Delivery Order SPE2DB22D3016-SPE2DB25FBEW7
- Not listed
- The Defense Logistics Agency awarded a $1,007.15 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This contract represents a firm fixed-price delivery order with an ultimate completion date of August 1, 2025, and carries no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,996.74 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets in a quantity of 56 units. The contract was awarded on May 22, 2025, with an ultimate completion date of May 23, 2025, and utilizes firm fixed pricing with no set-aside designation. This delivery order represents a competitively awarded transaction under the company's existing federal contract vehicle, with performance to be fulfilled at...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Varenicline 1mg tablets (56-count packages) valued at $7,668.62, with completion scheduled for July 30, 2025. This competitive, firm fixed-price delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. The award was issued under a non-set-aside competitive process, reflecting AmerisourceBergen's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,703.41 by the Defense Logistics Agency on August 4, 2025, for the supply of Varenicline 1 mg tablets (56-count packages). This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion on August 5, 2025, with performance occurring at the contractor's Conshohocken facility. The award carries no set-aside designation, reflecting the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,103.69 to AmerisourceBergen Drug Corp for the supply of Varenicline 1 mg tablets (56-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs. This award carries no set-aside designation, indicating it was...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,508.67 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4565535452 VARENICLINE 1 MG TABLET 56S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract has a ceiling value of $3,055.43 and a completion date of April 24, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, to supply the U.S. Department of Defense with varenicline 0.5 mg tablets. The contract has a ceiling value of $2,522.62 and a period of performance through March 15, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Varenicline 1 mg tablets. The contract, valued at $1,806.76, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order, valued at $2,040.72, is for the supply of 56 tablets of Varenicline 1 mg, a prescription medication. The delivery order was issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBEW7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Varenicline 1 mg tablets (56-count packages) valued at $1,637.64. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 14, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a child contract under the vendor's larger supply relationship with the federal government. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving entities including the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor, AmerisourceBergen has demonstrated consistent capability to fulfill federal medical procurement requirements through competitive awards across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/13/25 |